FDA Investigator Shahla Parvizi
Shahla Parvizi has inspections in 1 countries as of 11 Jun 2019. Shahla Parvizi has collaborated with a combined 481 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
11 Jun 2019
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Barbara J Maulfair,
Charles J Chacko,
Daniel J Grabicki,
Douglas C Kovacs,
Emest F Bizjak,
Emmanuel J Ramos,
Gianine E Tompkins,
Guerlain Ulysse,
Haitao Li,
Jose M Cayuela,
Justine Tomasso,
Karen E D'orazio,
Kelli F Dobilas,
Krishnaiah Yellela,
Kristy A Zielny,
Lata C Mathew, PhD,
Li Li,
Liatte Kreuger, PharmD,
Maria Manzoni, PhD,
Melissa T Roy,
Michael R Klapal,
Nancy F Scheraga,
Nicholas A Violand,
Regina T Brown,
Sinai Davis,
Stephen J Mottola,
Yvins Dezan,
Zakaria I Ganiyu
Shahla Parvizi's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2012 | FDA 483 | LTS Lohmann Therapy Systems Corp. - Form 483, 2012-09-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more